{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:21:46Z","timestamp":1793906506088,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autoimmune polyendocrine syndrome type 1 (APS-1) is a rare monogenic disease caused by mutations in the autoimmune regulator gene. Although the disease-associated autoantibodies mostly target endocrine organs, autoantibodies from patients with APS-1 bind also to rat brain structures. The patients often have GAD65-antibodies, that can cause autoimmune encephalitis. However, neurological manifestations of APS-1 have not been systematically explored. We conducted a retrospective chart review on 44 Finnish patients with APS-1 (median age 38 years, 61% females) and collected all their neurological diagnoses. To assess the prevalence of serum antineuronal antibodies in APS-1, serum samples of 24 patients (median age 36 years, 63% females) were analyzed using a fixed cell-based assay. Of the 44 APS-1 patients, 10 (23%) had also received a diagnosis of a neurological disease. Of these neurological comorbidities, migraine (<jats:italic>n<\/jats:italic>\u2009=\u20097; 16%), central nervous system infections (<jats:italic>n<\/jats:italic>\u2009=\u20093; 7%), and epilepsy (<jats:italic>n<\/jats:italic>\u2009=\u20092; 5%) were the most prevalent. Other diagnoses recorded for single patients were axonal sensorimotor polyneuropathy, essential tremor, idiopathic intracranial hypertension, ischemic stroke, and trigeminal neuralgia. Serum antineuronal antibodies were detected in 42% of patients tested (10\/24, 50% females, median age 42 years), GAD65 antibodies being the most common finding. Antibodies against glycine and aquaporin 4 were found in low titers. In four patients, relatively high titers of GAD65 antibodies without coexisting type 1 diabetes were found, but none presented with GAD65-encephalitis. Our study suggests an association between APS-1 and neurological disorders, the mechanisms of which are to be further investigated.<\/jats:p>","DOI":"10.1007\/s10875-024-01748-z","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T08:01:59Z","timestamp":1717401719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neurological Diseases and Prevalence of Antineuronal Antibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 \u2013 A National Cohort Study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-2849","authenticated-orcid":false,"given":"Sini M","family":"Laakso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aino","family":"H\u00e4kkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saila","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"issue":"8","key":"1748_CR1","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1210\/jc.2005-2611","volume":"91","author":"J Perheentupa","year":"2006","unstructured":"Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metabolism. 2006;91(8):2843\u201350.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"9","key":"1748_CR2","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1210\/jc.2017-00139","volume":"102","author":"E Orlova","year":"2017","unstructured":"Orlova E, Sozaeva L, Kareva M, Oftedal B, Wolff A, Breivik L, et al. Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metabolism. 2017;102(9):3546\u201356.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"4","key":"1748_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri.2016.9","volume":"16","author":"M Anderson","year":"2016","unstructured":"Anderson M, Su M. AIRE expands: new roles in immune tolerance and beyond. Nat Rev Immunol. 2016;16(4):247\u201358.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1748_CR4","first-page":"103","volume":"287","author":"M Lionakis","year":"2018","unstructured":"Lionakis M, Constantine G. Lessons from primary immunodeficiencies: autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Immunol Rev. 2018;287(1):103\u201320.","journal-title":"Immunol Rev"},{"issue":"2","key":"1748_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/002215540104900207","volume":"49","author":"M Halonen","year":"2001","unstructured":"Halonen M, Pelto-Huikko M, Eskelin P, Peltonen L, Ulmanen I, Kolmer M. Subcellular location and expression pattern of Autoimmune Regulator (Aire), the mouse Orthologue for Human Gene defective in APS-1. J Histochem Cytochemistry. 2001;49(2):197\u2013208.","journal-title":"J Histochem Cytochemistry"},{"issue":"2","key":"1748_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.imlet.2006.06.006","volume":"106","author":"T Klamp","year":"2006","unstructured":"Klamp T, Sahin U, Kyewski B, Schwenndemann J, Dhaene K, Tureci O. Expression profiling of autoimmune regulator AIRE mRNA in a comprehensive set of human normal and neoplastic tissues. Immunol Lett. 2006;106(2):172\u20139.","journal-title":"Immunol Lett"},{"key":"1748_CR7","doi-asserted-by":"publisher","first-page":"e55053","DOI":"10.7554\/eLife.55053","volume":"9","author":"S Vazquez","year":"2020","unstructured":"Vazquez S, Ferre E, Scheel D, Sunshine S, Miao B, Mandel-Brehm C, et al. Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-seq. eLife. 2020;9:e55053.","journal-title":"eLife"},{"issue":"1","key":"1748_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.21913","volume":"513","author":"S Fetissov","year":"2009","unstructured":"Fetissov S, Bensing S, Mulder J, Le Maitre E, Hulting A, Harkany T. Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems. J Comp Neurol. 2009;513(1):1\u201320.","journal-title":"J Comp Neurol"},{"key":"1748_CR9","doi-asserted-by":"crossref","unstructured":"Garelli S, Costa M, Sabbadin C, Barollo S, Rubin B, Scarpa R et al. Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients. J Endocrinol Investig. 2021.","DOI":"10.1007\/s40618-021-01585-6"},{"issue":"5","key":"1748_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1530\/EJE-08-0328","volume":"159","author":"KT Podkrajsek","year":"2008","unstructured":"Podkrajsek KT, Milenkovi\u0107 T, Odink RJ, Claasen-van der Grinten HL, Bratanic N, Hovnik T, et al. Detection of a complete autoimmune regulator gene deletion and two additional novel mutations in a cohort of patients with atypical phenotypic variants of autoimmune polyglandular syndrome type 1. Eur J Endocrinol. 2008;159(5):633\u20139.","journal-title":"Eur J Endocrinol"},{"key":"1748_CR11","doi-asserted-by":"publisher","first-page":"679164","DOI":"10.3389\/fneur.2021.679164","volume":"12","author":"G Kawano","year":"2021","unstructured":"Kawano G, Yokochi T, Nishikomori R, Watanabe Y, Ohbu K, Takahashi Y, et al. Case Report: Rituximab Improved epileptic spasms and EEG abnormalities in an infant with West Syndrome and Anti-NMDAR Encephalitis Associated with APECED. Front Neurol. 2021;12:679164.","journal-title":"Front Neurol"},{"key":"1748_CR12","doi-asserted-by":"crossref","unstructured":"Kopczak A, Schumacher A, Nischwitz S, Kumpfel T, Stalla G, Auer M. GAD antibody-associated limbic encephalitis in a young woman with APS-1. Endocrinology, Diabetes & Metabolism. 2017; 17\u2009\u2013\u20090010.","DOI":"10.1530\/EDM-17-0010"},{"key":"1748_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fped.2019.00051","volume":"7","author":"M Chinello","year":"2019","unstructured":"Chinello M, Mauro M, Cantalupo G, Balter R, De Bortoli M, Vitale V, et al. Pure red cell aplasia (PRCA) and cerebellar hypoplasia as atypical features of polyglandular autoimmune syndrome type I (APS-1): two sisters with the same AIRE mutation but different phenotypes. Front Pead. 2019;7:51.","journal-title":"Front Pead"},{"key":"1748_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00431-008-0736-8","volume":"168","author":"M Valenzise","year":"2009","unstructured":"Valenzise M, Meloni A, Betterle C, Giometto B, Autunno M, Mazzeo A, et al. Chronic inflammatory demyelinating polyneuropathy as a possible novel component of autoimmune polyendocrine-candidiasis-ectodermal dystrophy. Eur J Pediatrics. 2009;168:237\u201340.","journal-title":"Eur J Pediatrics"},{"issue":"23","key":"1748_CR15","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1212\/01.wnl.0000313837.45525.b6","volume":"70","author":"J Berger","year":"2008","unstructured":"Berger J, Weaver A, Greenlee J. Neurologic consequences of autoimmune polyglandular syndrome type 1. Neurology. 2008;70(23):2248\u201351.","journal-title":"Neurology"},{"issue":"10","key":"1748_CR16","first-page":"702","volume":"20","author":"J Gazulla Ab\u00edo","year":"2005","unstructured":"Gazulla Ab\u00edo J, Benavente Aguilar I, Ricoy Campo JR, Madero Barraj\u00f3n P. Miopat\u00eda con fibras trabeculares asociada a s\u00edndrome poliglandular autoinmune tipo 1 familiar [Myopathy with trabecular fibers associated with familiar autoimmune polyglandular syndrome type 1]. Neurologia. 2005;20(10):702\u20138.","journal-title":"Neurologia"},{"issue":"262","key":"1748_CR17","first-page":"139","volume":"70","author":"RA Evans","year":"1989","unstructured":"Evans RA, Carter JN, Shenston B, Smith A, Hills E, Walls R, et al. Candidiasis-Endocrinopathy syndrome with progressive myopathy. Q J Med. 1989;70(262):139\u201344.","journal-title":"Q J Med"},{"key":"1748_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2265.2010.03952.x","volume":"74","author":"S Storz","year":"2011","unstructured":"Storz S, Wylenzek S, Matheis N, Weber M, Kahaly G. Impaired psychometric testing in polyglandular autoimmunity. Clin Endocrinol. 2011;74:394\u2013403.","journal-title":"Clin Endocrinol"},{"issue":"10","key":"1748_CR19","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00702-017-1754-3","volume":"124","author":"J Baizabal-Carvallo","year":"2017","unstructured":"Baizabal-Carvallo J, Alonso-Juarez M. Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review. J Neural Transm. 2017;124(10):1171\u201382.","journal-title":"J Neural Transm"},{"issue":"3","key":"1748_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1552-6569.2010.00542.x","volume":"22","author":"M Manto","year":"2012","unstructured":"Manto M, Jissendi P. Brain imaging in cerebellar ataxia associated with autoimmune polyglandular syndrome type 2. J Neuroimaging. 2012;22(3):308\u201311.","journal-title":"J Neuroimaging"},{"issue":"3","key":"1748_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1365-2249.2002.01931.x","volume":"29","author":"M Costa","year":"2002","unstructured":"Costa M, Saiz A, Casamitjana R, Castener M, Sanmarti A, Graus F, et al. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin Exp Immunol. 2002;29(3):471\u20138.","journal-title":"Clin Exp Immunol"},{"key":"1748_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fendo.2020.00109","volume":"11","author":"S Laakso","year":"2020","unstructured":"Laakso S, Borchers J, Toiviainen-Salo S, Pekkinen M, M\u00e4kitie O. Severe phenotype of APECED (APS1) increases risk for structural bone alterations. Front Endocrinol (Lausanne). 2020;11:109.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1748_CR23","unstructured":"Labor, St\u00f6cker. March, [https:\/\/www.labor-stoecker.de\/], viewed 8th 2024."},{"key":"1748_CR24","doi-asserted-by":"publisher","first-page":"108851","DOI":"10.1016\/j.clim.2021.108851","volume":"231","author":"I Hetem\u00e4ki","year":"2021","unstructured":"Hetem\u00e4ki I, Laakso S, V\u00e4limaa H, Kleino I, Kek\u00e4l\u00e4inen E, M\u00e4kitie O, et al. Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections. Clin Immunol. 2021;231:108851.","journal-title":"Clin Immunol"},{"issue":"1","key":"1748_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s10194-019-0964-5","volume":"20","author":"MA Korolainen","year":"2019","unstructured":"Korolainen MA, Kurki S, Lassenius MI, Toppila I, Costa-Scharplatz M, Purmonen T, et al. Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care. J Headache Pain. 2019;20(1):13.","journal-title":"J Headache Pain"},{"key":"1748_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1528-1157.1992.tb01689.x","volume":"33","author":"M Sillanp\u00e4\u00e4","year":"1992","unstructured":"Sillanp\u00e4\u00e4 M. Epilepsy in children: prevalence, disability, and handicap. Epilepsia. 1992;33:444\u20139.","journal-title":"Epilepsia"},{"key":"1748_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.yebeh.2008.08.007","volume":"14","author":"E L\u00f6fgren","year":"2009","unstructured":"L\u00f6fgren E, Pouta A, von Wendt L, Tapanainen J, Isoj\u00e4rvi JI, J\u00e4rvelin MR. Epilepsy in the northern Finland birth cohort 1966 with special reference to fertility. Epilepsy Behav. 2009;14:102\u20137.","journal-title":"Epilepsy Behav"},{"key":"1748_CR28","doi-asserted-by":"publisher","unstructured":"Sipil\u00e4 JOT. Adult-onset encephalitis over two decades in easternmost Finland. Neuroepidemiology. 2024 Feb;28. https:\/\/doi.org\/10.1159\/000538020.","DOI":"10.1159\/000538020"},{"issue":"9","key":"1748_CR29","doi-asserted-by":"publisher","first-page":"e20230661","DOI":"10.1084\/jem.20230661","volume":"220","author":"A Gervais","year":"2023","unstructured":"Gervais A, Rovida F, Avanzini MA, Croce S, Marchal A, Lin SC, et al. Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in \u223c40% of patients. J Exp Med. 2023;220(9):e20230661.","journal-title":"J Exp Med"},{"key":"1748_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/jnnp-2020-325275","volume":"92","author":"A Budhram","year":"2021","unstructured":"Budhram A, Sechi E, Flanagan EP, Dubey D, Zekeridou A, Shah SS, et al. Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021;92:645\u201354.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1748_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/mus.25565","volume":"56","author":"A McKeon","year":"2017","unstructured":"McKeon A, Tracy JA. GAD65 neurological autoimmunity. Muscle Nerve. 2017;56(1):15\u201327.","journal-title":"Muscle Nerve"},{"issue":"3","key":"1748_CR32","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1212\/NXI.0000000000000696","volume":"7","author":"A Mu\u00f1oz-Lopetegi","year":"2020","unstructured":"Mu\u00f1oz-Lopetegi A, de Bruijn MAAM, Boukhrissi S, Bastiaansen AEM, Nagtzaam MMP, Hulsenboom ESP, et al. Neurologic syndromes related to anti-GAD65: clinical and serologic response to treatment. Neurol Neuroimmunol Neuroinflamm. 2020;7(3):e696.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"1748_CR33","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.2337\/dc15-0305","volume":"38","author":"O Rolandsson","year":"2015","unstructured":"Rolandsson O, Hampe CS, Wennberg P, Radtke J, Langenberg C, Wareham N, et al. Prevalence and Regional Distribution of Autoantibodies against GAD65Ab in a European Population without Diabetes: the EPIC-InterAct study. Diabetes Care. 2015;38(8):e114\u20135.","journal-title":"Diabetes Care"},{"issue":"12","key":"1748_CR34","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1002\/acn3.51486","volume":"8","author":"A Dik","year":"2021","unstructured":"Dik A, Widman G, Schulte-Mecklenbeck A, Witt JA, Pitsch J, Golombeck KS, et al. Impact of T cells on neurodegeneration in anti-GAD65 limbic encephalitis. Ann Clin Transl Neurol. 2021;8(12):2289\u2013301.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1748_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13023-018-0787-5","volume":"13","author":"S Liimatainen","year":"2018","unstructured":"Liimatainen S, Honnorat J, Pittock SJ, McKeon A, Manto M, Radtke JR, et al. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies. Orphanet J Rare Dis. 2018;13(1):55.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01748-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01748-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01748-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T08:16:00Z","timestamp":1719562560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01748-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1748"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01748-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethical committee of Helsinki University Hospital (HUS\/1785\/2016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study or their guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors affirm that human research participants or their guardians provided informed consent for publication of the research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"140"}}